Sale

Biosensors Market

Global Biosensors Market Share, Size, Analysis, Segmentation: By Product: Wearable, Non-Wearable; By Technology: Electrochemical, Optical, Piezoelectric, Thermal Biosensors, Nanomechanical; By Component: Bioreceptor Molecule, Biological Element, Transducer; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Biosensors Market Outlook

The global biosensors market value was USD 7.5 billion in 2023, driven by the growing demand for point-of-care testing across the globe. The market size is anticipated to grow at a CAGR of 6.4% during the forecast period of 2024-2032 to achieve a value of USD 13.1 billion by 2032.

 

Wearable Segment to Account for a Substantial Share of the Global Biosensors Industry

Based on product, the wearable segment is expected to hold a significant share in the global biosensors industry in the forecast period. This growth can be attributed to the rising incidences of diabetes and cardiovascular diseases, which require regular monitoring and instant diagnostics. These are portable and allow people to have a home-based diagnosis, which is cost-effective and reduces the time required for the diagnosis. In addition, through wearable biosensors, patients can keep track of their real-time health situation, which helps in effective treatment and early detection of diseases, which could reduce the mortality risk.

 

Biosensors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Exhibit a Significant Growth in the Global Biosensors Industry

The North America region is predicted to occupy a considerable share of the global biosensors industry. This surge can be attributed to the increased implementation of biosensors in the region. In addition, this growth is due to the rising incidences of illnesses, which can be tracked and monitored by biosensors in the region, such as diabetes. According to the statistics provided by the American Diabetes Association, diabetes is the 7th primary cause of death in the United States, and around 1.5 million Americans are diagnosed with diabetes every year. In addition, the growing use of biosensors in the food and beverage industry has further boosted the market share of the region in the global biosensors industry.

 

Biosensors: Market Segmentation

Biosensors are self-containing analytical devices that are used to detect the presence of a biological analyte. It recognises the analyte and produces a measurable signal. The device comprises a transducer and a biological component such as an enzyme, which reacts upon interaction with a biological analyte. This biological reaction is converted into an electrical signal by the transducer. Biosensors are used in multiple ways and can, therefore, be referred to as immunosensor, optrodes, glucometers, biocomputers and biochips, among others. Some commonly found biosensors include store-bought pregnancy tests and glucose detectors.

 

Biosensors Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product, the market is bifurcated into:

  • Wearable 
  • Non-Wearable

On the basis of technology, the industry can be categorised into:

  • Electrochemical 
  • Optical
  • Piezoelectric
  • Thermal Biosensors
  • Nanomechanical

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rapid Technological Advancements and the Rising Instances of Chronic Illnesses to Bolster the Growth of the Global Biosensors Industry

Biosensors are increasingly being utilised in biomedicine, food safety standards, defence , security, and environmental monitoring, and with rapid advancements, the biosensor devices have become extremely helpful in the healthcare sector. Emerging trends of nanotechnology-based biosensors have increased the sensitivity limit of biosensors. Furthermore, the rising spread of chronic diseases such as cancer, diabetes, and other cardiovascular diseases has increased the demand for biosensors in the market, such as biosensors for blood glucose monitoring, pregnancy tests, and cholesterol monitoring. In addition, with the advent of coronavirus and its rapid spread, consumers are investing in oximeters, which are biosensors that monitor oxygen and blood pressure levels. These are some of the factors that are expected to impact the overall growth of the biosensors industry positively.

 

Biosensors Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Key Industry Players in the Global Biosensors Market

The report gives a detailed analysis of the following key players in the global biosensors market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • AgaMatrix Holdings LLC
  • Abott Laboratories Inc.
  • Biosensors International Groups Ltd.
  • Medtronic Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Technology
  • Component
  • Application
  • End User
  • Region
Breakup by Product
  • Wearable
  • Non-Wearable
Breakup by Technology
  • Electrochemical
  • Optical
  • Piezoelectric
  • Thermal Biosensor
  • Nanomechanical
Breakup by Component
  • Bioreceptor Molecule
  • Biological Element
  • Transducer
Breakup by Application
  • POC
  • Home Diagnostic
  • Research Labs
  • Environmental Monitoring
  • Food and Beverages
  • Biodefence
Breakup by End User
  • Home Healthcare Diagnostics
  • POC Testing
  • Food Industry
  • Research Laboratories
  • Security and Biodefence
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AgaMatrix Holdings LLC
  • Abbott Laboratories Inc.
  • Biosensors International Group, Ltd.
  • Medtronic Inc.
  • Bio-Rad Laboratories Inc.
  • Pinnacle Technologies Inc.
  • Ercon, Inc.
  • Dupont Biosensors Materials
  • Koninklijke Philips N.V.
  • Qtl Biodetection Llc.
  • Molecular Devices Corporation
  • Nova Biomedical
  • Molex Llc
  • Zimmer & Peacock As
  • Siemens Healthcare

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology 
2    Executive Summary
3    Global Biosensors Market Overview  

    3.1    Global Biosensors Market Historical Value (2017-2023) 
    3.2    Global Biosensors Market Forecast Value (2024-2032)
4    Global Biosensors Market Landscape 
    4.1    Global Biosensors Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Biosensors Product Landscape
        4.2.1    Analysis by Type of Biosensor
        4.2.2    Analysis by Technology Used
        4.2.3    Analysis by Applications
5    Global Biosensors Market Dynamics 
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Biosensors Market Segmentation  
    6.1    Global Biosensors Market by Product
        6.1.1    Market Overview
        6.1.2    Wearable
            6.1.2.1    Wristwear
            6.1.2.2    Eyewear
            6.1.2.3    Footwear
            6.1.2.4    Neckwear
            6.1.2.5    Bodywear
            6.1.2.6    Others
        6.1.3    Non-Wearable
    6.2    Global Biosensors Market by Technology
        6.2.1    Market Overview
        6.2.2    Electrochemical
            6.2.2.1    Amperometric Sensor
            6.2.2.2    Potentiometric Sensor
            6.2.2.3    Conductometric Sensor
        6.2.3    Optical
            6.2.3.1    SPR
            6.2.3.2    Colorimetric Biosensors
            6.2.3.3    Fluorescence Biosensors
        6.2.4    Piezoelectric
            6.2.4.1    Acoustic Biosensors
            6.2.4.2    Microcantilever Biosensors
        6.2.5    Thermal Biosensor
        6.2.6    Nanomechanical
    6.3    Global Biosensors Market by Component
        6.3.1    Market Overview
        6.3.2    Bioreceptor Molecule
        6.3.3    Biological Element
        6.3.4    Transducer
    6.4    Global Biosensors Market by Application
        6.4.1    Market Overview
        6.4.2    POC
            6.4.2.1    Glucose Monitoring
            6.4.2.2    Cardiac Marker
            6.4.2.3    Infectious Disease Detection
            6.4.2.4    Coagulation Monitoring
            6.4.2.5    Pregnancy Testing
            6.4.2.6    Blood Gas and Electrolyte Detection
            6.4.2.7    Detection of Tumor or Cancer Marker
            6.4.2.8    Urinalysis Testing
            6.4.2.9    Cholesterol Testing
        6.4.3    Home Diagnostic
            6.4.3.1    Glucose Monitoring
            6.4.3.2    Pregnancy Testing
            6.4.3.3    Cholesterol Testing
        6.4.4    Research Labs
        6.4.5    Environmental Monitoring
        6.4.6    Food and Beverages
        6.4.7    Biodefence
    6.5    Global Biosensors Market by End User
        6.5.1    Market Overview
        6.5.2    Home Healthcare Diagnostics
        6.5.3    POC Testing
        6.5.4    Food Industry
        6.5.5    Research Laboratories
        6.5.6    Security and Biodefence
    6.6    Global Biosensors Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Bladder Cancer Treatment Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada 
8    Europe Bladder Cancer Treatment Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Bladder Cancer Treatment Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Bladder Cancer Treatment Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Bladder Cancer Treatment Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework 
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    AgaMatrix Holdings LLC
        17.1.1    Financial Analysis 
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Abbott Laboratories Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Biosensors International Group, Ltd.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Medtronic Inc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Bio-Rad Laboratories Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Pinnacle Technologies Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Ercon, Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Dupont Biosensors Materials
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Koninklijke Philips N.V.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Qtl Biodetection Llc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Molecular Devices Corporation
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Nova Biomedical
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Molex Llc
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Zimmer & Peacock As
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Siemens Healthcare
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
18    Global Biosensors Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies 
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The biosensors market was valued at USD 7.5 billion in 2023.

The market is expected to grow at a CAGR of 6.4% from 2024 to 2032 to reach USD a value of USD 13.1 billion by 2032.

The major drivers of the market include the increased demand for biosensors like oximeters, the growing concerns of cancer and diabetes, favourable properties such as user-friendly interface and portability, rapidly growing geriatric population, and multifaceted application possibilities of the biosensor technology.

The key trends guiding the growth of the market include the rapid technological advancements and heightened investments in the R&D of biosensors technology.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant product segments include wearable and non-wearable.

The major segments based on technology include electrochemical, optical, piezoelectric, thermal biosensors, and nanomechanical.

The major players in the market are AgaMatrix Holdings LLC, Abott Laboratories Inc., Biosensors International Groups Ltd., and Medtronic Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER